Lipoprotein-associated phospholipase A2 is especially predictive of coronary artery disease among patients with the metabolic syndrome

被引：0
|
作者：
Lavasani, Farangis
May, Heidi T.
Horne, Benjamin D.
Anderson, Jeffrey L.
Carlquist, John F.
Wolfert, Robert L.
Pearson, Robert R.
Lanman, Richard B.
Muhlestein, Joseph B.
机构：
[1] LDS Hosp, Salt Lake City, UT USA
[2] Univ Utah, Salt Lake City, UT USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 49卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：339A / 339A
页数：1
相关论文
共 50 条
  • [1] Lipoprotein-associated Phospholipase A2 in Coronary Artery Disease
    Dimitroglou, Yannis
    Sakalidis, Athanasios
    Mavroudis, Andreas
    Kalantzis, Charalambos
    Valatsou, Angeliki
    Andrikou, Ioannis
    Christofi, Angela
    Mantzouranis, Emmanouil
    Kachrimanidis, Ioannis
    Bei, Evellina
    Lazarou, Emilia
    Tsioufis, Costas
    Tousoulis, Dimitris
    Lazaros, George
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2022, 22 (28) : 2344 - 2354
  • [2] Lipoprotein-associated phospholipase a2 in a population of patients with metabolic syndrome
    Rosenbaum, D.
    Hansel, B.
    Bittar, R.
    Charniot, J. C.
    Girerd, X.
    Bruckert, E.
    Rousselot, D. Bonnefont
    Giral, P.
    EUROPEAN HEART JOURNAL, 2010, 31 : 695 - 696
  • [3] Lipoprotein-associated Phospholipase A2 Levels Are Associated With Vascular Function in Patients With Coronary Artery Disease
    Siasos, Gerasimos
    Oikonomou, Evangelos
    Zaromitidou, Marina
    Mourouzis, Kostas
    Miliou, Antigoni
    Georgiopoulos, Georgios
    Antonopoulos, Alexis
    Papamikroulis, Georgios Angelos
    Vogiatzi, Georgia
    Tsalamandris, Sotirios
    Vavuranakis, Manolis
    Tousoulis, Dimitris
    CIRCULATION, 2016, 134
  • [4] Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease
    Sofogianni, Areti
    Alkagiet, Stelina
    Tziomalos, Konstantinos
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (03) : 291 - 296
  • [5] The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease
    Zhang, Hao
    Gao, Yang
    Wu, Dan
    Zhang, Dingguo
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [6] The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease
    Hao Zhang
    Yang Gao
    Dan Wu
    Dingguo Zhang
    BMC Cardiovascular Disorders, 20
  • [7] Lipoprotein-associated phospholipase A2 and cardiovascular events in high risk coronary artery disease patients
    Maiolino, G.
    Pedon, L. P.
    Cesari, M. C.
    Frigo, A. C.
    Barisa, M.
    Rossitto, G.
    Pagliani, L.
    Seccia, T. M.
    Zanchetta, M.
    Paolo, G. P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 1076 - 1076
  • [8] The role of lipoprotein-associated phospholipase A2 in the metabolic syndrome and diabetes
    Noto, Hiroshi
    Chitkara, Pranav
    Raskin, Philip
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2006, 20 (06) : 343 - 348
  • [9] Lipoprotein-associated Phospholipase A2 is Associated with Angiographic Coronary Artery Disease and Coronary Artery Risk Factors in the Elderly
    Dong, Lini
    Qu, Xiaobing
    Hu, Zhi Gao
    Peng, Xiaoli
    Wang, Yanjiao
    Miao, Qin
    Zhang, Xiangyu
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2015, 9 (02) : 82 - 86
  • [10] Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
    Gong, Hui-ping
    Du, Yi-meng
    Zhong, Li-na
    Dong, Zhao-qiang
    Wang, Xin
    Mao, Yong-jun
    Lu, Qing-hua
    LIPIDS IN HEALTH AND DISEASE, 2011, 10
12345